CAREER DEVELOPMENT PROGRAM

爱荷华大学/梅奥临床淋巴瘤孢子(UI/MC孢子)职业发展目标 该计划(CDP)旨在培养知识渊博、训练有素、具有多学科研究经验的科学家 在转化性淋巴瘤研究方面的未来研究。提供充足的培训和培训机会 职业发展是爱荷华大学和梅奥诊所科学界的首要任务。这个 CDP代表了UI/MC孢子中的一个关键的“生长”区域，并允许我们招募两个聪明、精力充沛的 孢子研究的新调查人员。这两家公司拥有广泛的研究和培训基地 机构为孢子CDP提供了强有力的支持。CDP的主要目标是培养年轻的 研究人员(高级博士后研究员和年轻教员)翻译、多学科基础、临床或 基于人群的淋巴瘤研究。在最近的资助期(5-9岁)，5名青年 调查人员获得了CDP奖，每人得到了1-2年的支持。他们都保持活跃 孢子内的转化型淋巴瘤调查人员。孢子CDP将为一个提供高达50,000美元 年(25,000美元来自孢子基金，25,000美元来自爱荷华大学和梅奥诊所 资源)，分别获得两个奖项。根据进展情况，可能再提供一年的支助 成功的复赛。在下一个资助期，UI/MC淋巴瘤孢子将保持：(1) 严格的候选人遴选制度；(2)由培训员进行全面的实习生指导；(3)通过 科学指导小组(个人见习指导委员会)由调查人员组成， 每个受训人员感兴趣领域的专门知识；(4)多学科研究课程和持续培训 在两个地点举行的多学科癌症研讨会系列和淋巴瘤小组会议等活动； (5)鼓励与调查小组在两个地点的会议合作；(6)鼓励 与爱荷华州和梅奥的研究人员合作以及(7)加强研究的机会 通过发展研究计划。

The goal of the University of lowa/Mayo Clinic Lymphoma SPORE (UI/MC SPORE) Career Development Program (CDP) is to develop knowledgeable, well-trained scientists experienced in multidisciplinary research for future studies in translational lymphoma research. The provision of ample opportunities for training and career enhancement is a top priority of the University of lowa and Mayo Clinic scientific communities. The CDP represents a key "growth'' area within the UI/MC SPORE and allows us to recruit two bright, energetic new investigators into SPORE research. The extensive research and training base available at these two institutions provides strong support for the SPORE CDP. The primary objective of the CDP is to train young investigators (senior postdoctoral fellows and young faculty) in translational, multidisciplinary basic, clinical or population-based lymphoma research. During this most recent funding period (years 5-9), 5 young investigators received CDP awards and were each supported for 1-2 years. They all remain active translational lymphoma investigators within the SPORE. The SPORE CDP will provide up to $50,000 for one year ($25,000 from SPORE funds and a matching $25,000 from the University of lowa and Mayo Clinic resources) for each of two awards. An additional year of support is possible based on progress and successful re-competition. During the next funding period, the UI/MC Lymphoma SPORE will maintain: (1) a stringent candidate selection system; (2) comprehensive trainee guidance by a menter; (3) support through a scientific mentor group (the Individual Trainee Mentorship Committee) comprised of investigators with expertise in each trainee's area of interest; (4) multi-disciplinary research courses and on-going training activities such as the Multidisciplinary Cancer Seminar Series and Lymphoma Group meetings at both sites; (5) encouragement of collaboration with Investigator Group meetings at both sites; (6) encouragement of collaboration with investigators at both lowa and Mayo and (7) opportunities for research enhancement through the Developmental Research Program.